1. "American Society of Clinical Oncology"
  2. "Melanoma and Immunotherapeutics Service"
Formats
  1. Meeting Abstract (249)
  2. Journal Article (70)
  3. Editorial (6)
  4. Correspondence (1)
  5. Guidelines (1)
Groups
  1. Department of Medicine (327)
  2. Melanoma and Immunotherapeutics Service (327)
  3. Solid Tumor Oncology Division (327)
  4. GSK Faculty (189)
  5. Melanoma Disease Management Team (143)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (108)

More Groups

People
  1. Jedd Wolchok (171)
  2. Paul Chapman (94)
  3. Michael Postow (82)
  4. Alexander Shoushtari (63)
  5. Margaret Callahan (62)
  6. Katherine Panageas (42)

More People

Years
  1. 2023 (18)
  2. 2022 (20)
  3. 2021 (20)
  4. 2020 (17)
  5. 2019 (23)
  6. 2018 (33)

More Years

Publications
  1. Journal of Clinical Oncology (316)
  2. American Society of Clinical Oncology Educational Book (5)
  3. JCO Precision Oncology (5)
  4. JCO Clinical Cancer Informatics (1)
Publishers
  1. American Society of Clinical Oncology (327)

Results (327)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A pilot trial of autologous tumor infiltrating lymphocytes (lifileucel, LN-144) for patients with asymptomatic melanoma brain metastases
    Meeting Abstract

    Betof Warner, A.; Postow, M. A.; Panageas, K.; Smithy, J. W.; Schoenfeld, A. J.; Wolchok, J. D.; Shoushtari, A. N.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase 2/3 trial in progress on tebentafusp as monotherapy and in combination with pembrolizumab in HLA-A*02:01+ patients with previously treated advanced non-uveal melanoma (TEBE-AM)
    Meeting Abstract

    Davar, D.; Ikeguchi, A.; Buchbinder, E. I.; Shoushtari, A. N.; Seedor, R. S.; Bernicker, E.; Weiss, S. A.; Daniels, G. A.; Panella, T. J.; Ryan, H. F.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Serum cytokines and autoantibodies to GM-CSF and immune-related colitis in ipilimumab-treated patients with cancer
    Meeting Abstract

    Gonzalez-Kozlova, E.; Del Valle, D.; Tuballes, K.; Barcessat, V.; King, S.; Huang, H. H.; Patel, M.; Cabal, R.; Ioannou, G.; Merand, R.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Fertility post immune checkpoint blockade
    Meeting Abstract

    Ogle, M.; Harrold, E.; O'Brien, E.; Weiss, J. A.; Yaqubie, A.; Sinopoli, J. C.; Postow, M. A.; Cercek, A.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Early ctDNA reduction may identify patients with stable disease and long OS on tebentafusp
    Meeting Abstract

    Feng, D.; Collins, L.; Callahan, M. K.; Sullivan, R. J.; Piperno-Neumann, S.; Nathan, P. D.; Hassel, J. C.; Goodall, H.; Holland, C.; Ranade, K.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Melanomas lacking HLA class I expression and response to checkpoint inhibitor
    Meeting Abstract

    Chapman, P. B.; Jayaprakasam, V. S.; Callahan, M. K.; Shoushtari, A. N.; Postow, M. A.; Lezcano, C.; Wolchok, J. D.; Nandakumar, S.; Chatila, W. K.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Targeting AMP kinase in melanoma: A phase I trial of phenformin with dabrafenib/trametinib
    Meeting Abstract

    Chapman, P. B.; Klang, M.; Postow, M. A.; Shoushtari, A. N.; Sullivan, R. J.; Wolchok, J. D.; Wong, P.; Callahan, M. K.; Zippin, J.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Durable clinical outcomes in patients (pts) with advanced melanoma and progression-free survival (PFS) ≥3y on nivolumab (NIVO) ± ipilimumab (IPI) or IPI in checkmate 067
    Meeting Abstract

    Hodi, F. S.; Chiarion-Sileni, V.; Gonzalez, R.; Grob, J. J.; Rutkowski, P.; Lao, C. D.; Cowey, C. L.; Schadendorf, D.; Wagstaff, J.; Dummer, R.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Final clinical results and first translational correlates of a phase 2 trial of adaptively dosed nivolumab and ipilimumab based on early radiographic assessment in advanced melanoma (ADAPT-IT)
    Meeting Abstract

    Smithy, J. W.; Kalvin, H. L.; Raber, V.; Maher, C. A.; Kleman, J.; McIntyre, D. A. G.; Shoushtari, A. N.; Betof Warner, A.; Callahan, M. K.; Momtaz, P.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • The effect of LNS8801 alone and in combination with pembrolizumab in patients with metastatic uveal melanoma
    Meeting Abstract

    Shoushtari, A. N.; Chaney, M. F.; Cohen, J. V.; Garyantes, T.; Lin, J. J.; Ishizuka, J. J.; Mita, A. C.; Mita, M. M.; Muller, C.; Natale, C.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save